Combined Measles-Mumps-Rubella Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Combined Measles-Mumps-Rubella Vaccine, covering 2018-08-17 to 2018-08-17. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life [Phase 3]